Research article · 12 Jun 2025
Conference abstractPublished 2017
Investigation on nano-sized drug delivery systems for ocular application
University of Pisa, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The unique characteristics of the eye and the presence of strong defense mechanisms make difficult to achieve therapeutic concentrations of drug in the different parts of the eye after topical instillation of eye-drop. One of the main challenges to increase the poor ocular bioavailability of conventional formulations is to improve the low drug-contact time by reducing drainage, tear turnover and dilution or lacrimation. In addition, another strategy is to enhance the drug penetration across the cornea, which represents an effective barrier to drug permeation due to the presence of the annular tight junctions on corneal epithelium. Various drug delivery systems have been developed to increase the bioavailability of ophthalmic drug. In particular, nano-sized carriers like liposome, nanoparticle, SLN and nano-micelle have gained wide interest, providing an increase in the pre-corneal residence time, muco-adhesion and penetration across the eye tissues of drugs. Conventional delivery systems usually require administering at regular time intervals, whereas nano-sized carriers often release drugs at constant rate for a prolonged period of time and thus enhance their absorption and promote a site specific delivery especially when dispersed or suspended in polymer solutions with muco-adhesion properties. In fact, when applied topically as eye-drop, liposomes can attach to the hydrophobic corneal epithelium, where they continuously release the encapsulated drug, improving pharmacokinetics behavior and decreasing toxic side effects of encapsulated drugs. Polymeric nanoparticles protect drug from metabolic degradation and interact strongly with both ocular surface and drug, more than the same mucoadhesive polymer in solution. SLN for their lipophilic nature, favor drug permeation through the highly hydrophobic corneal epithelium and furthermore, transscleral route might contribute to drug absorption in vitreous humor. The consistent progress in formulation efficiency of nano-sized carriers will be described in view of their application in ophthalmic field.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Patrizia Chetoni”
